JNJ logo

Johnson & Johnson (JNJ)

Profile

Full Name

Johnson & Johnson

Ticker Symbol

JNJ

Exchange

NYSE

Sector

Healthcare

Industry

Drug Manufacturers - General

Country

United States

IPO

January 2, 1943

Indexes

S&P 500,Dow Jones

Website

http://www.jnj.com

Employees

138100

Key Details

Price

$157.47(+2.31%)

Market cap

$379.48B(Mega cap)

Last Dividend

$1.24

TTM Dividend yield

3.15%

Annual revenue

$88.82B(+4.30% YoY)

Annual EPS

$5.79(-57.80% YoY)

PE ratio

17.52

Next earnings date

Jul 16, 2025

Next ex-dividend date

May 27, 2025

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$157.47
JNJ price is $157.47

30-Day Relative Volume

0.82
JNJ 30-day relative volume is 0.82

Price Performance

Price Most recent change

+2.31%
JNJ price was up +2.31% on Apr 17, 2025

Price YTD change

+8.89%
JNJ price is up +8.89% since January 1st

Price 1-year change

+8.77%
JNJ price is up +8.77% year-on-year

Price 3-year change

-12.47%
JNJ price is down -12.47% over the past 3 years

Price Range

Price All-time high

$186.69
JNJ price is currently -15.65% below its historical high of $186.69

Price 3-year low

$140.68
JNJ price is currently +11.93% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$379.48B
JNJ market capitalization is $379.48 billion

Market cap 3-year change

-19.78%
JNJ market capitalization is down -19.78% over the past 3 years

Market cap All-time high

$489.47B
JNJ market capitalization is currently -22.47% below its historical high of $489.47 billion

Market cap sector rank

99.84%
JNJ market capitalization is higher than 99.84% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+0.13%
JNJ shares outstanding is up +0.13% year-on-year

Shares Outstanding 3-Year Change

-8.35%
JNJ shares outstanding is down -8.35% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

-0.01
JNJ beta is -0.01

200-day SMA

$156.75
JNJ price is currently +0.46% above its 200-day simple moving average

50-day SMA

$159.66
JNJ price is currently -1.37% below its 50-day simple moving average

RSI

51.20
JNJ 14-day relative strength index is 51.20

Volume

0.82
JNJ 30-day relative volume is 0.82

ATR

$4.60
JNJ average true range is $4.60

10-day Historical Volatility

31.46%
JNJ 10-day historical volatility is 31.46%

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Events

Last Paid Dividend

$1.24
JNJ last dividend was $1.24 per share, with an ex-dividend date of February 18, 2025

Next Dividend

$1.30
JNJ has announced a dividend of $1.30 per share, with an ex-dividend date set for May 27, 2025

Dividend per share

Dividend per share

$4.91
JNJ annual dividend per share is $4.91

Dividend per share Sector Rank

90.8%
JNJ annual dividend per share is higher than 90.8% of companies in Healthcare sector

Dividend per share 1-Year Change

+4.47%
JNJ annual dividend per share is up +4.47% year-on-year

Dividend per share 3-Year Change

+17.18%
JNJ annual dividend per share is up +17.18% over the past 3 years

Dividend yield

Dividend yield

3.12%
JNJ annual dividend yield is 3.12%

Dividend yield Sector Rank

62.79%
JNJ annual dividend yield is higher than 62.79% of companies in Healthcare sector

Other

Payout ratio

84.05%
JNJ annual payout ratio is 84.05%

Dividends paid

$11.82B
JNJ annual dividends paid is $11.82 billion

Free cash flow

$18.06B
JNJ annual free cash flow is $18.06 billion

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$88.82B
JNJ annual revenue is $88.82 billion

Revenue Analysts estimate

$91.05B
JNJ annual revenue is currently -2.44% lower than the consensus analysts' forecast

Revenue 1-year change

+4.3%
JNJ annual revenue is up +4.3% year-on-year

Revenue Sector rank

98.88%
JNJ annual revenue is higher than 98.88% of companies in Healthcare sector

EPS

EPS

$5.79
JNJ annual earnings per share is $5.79

EPS Analysts estimate

$10.52
JNJ annual earnings per share is currently -44.95% lower than the consensus analysts' forecast

EPS 1-year change

-57.8%
JNJ annual earnings per share is down -57.8% year-on-year

EPS Sector rank

96.35%
JNJ annual earnings per share is higher than 96.35% of companies in Healthcare sector

Profit

Gross profit

$61.35B
JNJ annual gross profit is $61.35 billion

Gross margin

69.07%
JNJ annual gross profit margin is 69.07%

Operating profit

$21.25B
JNJ annual operating income is $21.25 billion

Operating margin

23.92%
JNJ annual operating profit margin is 23.92%

Net income

$14.07B
JNJ annual net profit is $14.07 billion

Net margin

15.84%
JNJ annual net profit margin is 15.84%

Expenses

Total expenses

$67.57B
JNJ annual total expenses is $67.57 billion

Operating expenses

$40.10B
JNJ annual total operating expenses is $40.10 billion

Cost of goods sold

$27.47B
JNJ annual cost of goods sold is $27.47 billion

Selling, general & administrative expenses

$22.87B
JNJ annual SGA is $22.87 billion

Depreciation and amortization

$7.34B
JNJ annual depreciation & amortization is $7.34 billion

Interest expense

$755.00M
JNJ annual interest expense is $755.00 million

Income tax

$2.62B
JNJ annual income tax is $2.62 billion

EBIT & EBITDA

EBIT

$21.25B
JNJ annual earnings before interest & taxes is $21.25 billion

EBITDA

$21.25B
JNJ annual EBITDA is $21.25 billion

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$180.10B
JNJ annual total assets is $180.10 billion

Non current assets

$124.21B
JNJ annual long term assets is $124.21 billion

Current assets

$55.89B
JNJ annual total current assets is $55.89 billion

Cash and cash equivalents

$24.11B
JNJ annual cash & cash equivalents is $24.11 billion

Accounts receivable

$14.84B
JNJ annual accounts receivable is $14.84 billion

Inventory

$12.44B
JNJ annual inventory is $12.44 billion

Liabilities

Total liabilities

$108.61B
JNJ annual total liabilities is $108.61 billion

Long term liabilities

$58.29B
JNJ annual total long term liabilities is $58.29 billion

Current liabilities

$50.32B
JNJ annual total current liabilities is $50.32 billion

Accounts payable

$10.31B
JNJ annual accounts payable is $10.31 billion

Debt

Total debt

$36.63B
JNJ annual total debt is $36.63 billion

Total debt 1-year change

+24.89%
JNJ annual total debt is up +24.89% year-on-year

Long term debt

$30.65B
JNJ annual long term debt is $30.65 billion

Short term debt

$5.98B
JNJ annual short term debt is $5.98 billion

Equity & Capital

Shareholders equity

$71.49B
JNJ annual stockholders equity is $71.49 billion

Book value

$71.49B
JNJ annual book value is $71.49 billion

Retained earnings

-
JNJ annual retained earnings value is unknown

Working capital

$5.57B
JNJ annual working capital is $5.57 billion

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

$24.27B
JNJ annual cash flow from operations is $24.27 billion

Cash from operations 1-year change

+6.47%
JNJ annual cash flow from operations is up +6.47% year-on-year

Cash from investing

-$18.60B
JNJ annual cash flow from investing activities is -$18.60 billion

Cash from investing 1-year change

-2218.34%
JNJ annual cash flow from investing activities is down -2218.34% year-on-year

Cash from financing

-$3.13B
JNJ annual cash flow from financing activities is -$3.13 billion

Cash from financing 1-year change

+80.21%
JNJ annual cash flow from financing activities is up +80.21% year-on-year

CAPEX

CAPEX

$6.21B
JNJ annual capital expenditures is $6.21 billion

CAPEX 1-year change

+23.82%
JNJ annual capital expenditures is up +23.82% year-on-year

Free Cash Flow

Free cash flow

$18.06B
JNJ annual free cash flow is $18.06 billion

Free cash flow 1-year change

+1.58%
JNJ annual free cash flow is up +1.58% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

69.07%
JNJ annual gross profit margin is 69.07%

Operating margin

23.92%
JNJ annual operating profit margin is 23.92%

Net margin

15.84%
JNJ annual net profit margin is 15.84%

ROA & ROE

ROA

8.09%
JNJ annual return on assets is 8.09%

ROE

20.06%
JNJ annual return on equity is 20.06%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

17.52
JNJ price to earnings ratio is 17.52

PE ratio Sector rank

32.35%
JNJ price to earnings ratio is higher than 32.35% of companies in Healthcare sector

PB Ratio

PB ratio

-
JNJ price to book ratio value is unknown

PB ratio Sector rank

-
JNJ price to book ratio is unknown

PS Ratio

PS ratio

4.25
JNJ price to sales ratio is 4.25

PS ratio Sector rank

62.39%
JNJ price to sales ratio is higher than 62.39% of companies in Healthcare sector

Enterprise value

Enterprise value

-
JNJ enterprise value value is unknown

Enterprise value Sector rank

-
JNJ enterprise value is unknown

EV/EBITDA

EV/EBITDA

-
JNJ EV/EBITDA value is unknown

EV/EBITDA Sector rank

-
JNJ EV/EBITDA is unknown

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

1.11
JNJ annual current ratio is 1.11

Quick ratio

0.86
JNJ annual quick ratio is 0.86

Leverage

Debt to equity

0.51
JNJ annual debt to equity ratio is 0.51

Interest coverage ratio

28.14
JNJ annual interest coverage ratio is 28.14

Risk & Stability

Piotroski F-Score

-
JNJ piotroski f-score value is unknown

Altman Z-Score

-
JNJ altman z-score value is unknown

Analyst ratings

Recent major analysts updates

Apr 14, 25 Raymond James
Outperform
Apr 10, 25 B of A Securities
Neutral
Apr 9, 25 Morgan Stanley
Equal-Weight
Apr 9, 25 Goldman Sachs
Buy
Apr 3, 25 RBC Capital
Outperform
Apr 2, 25 RBC Capital
Outperform
Apr 2, 25 Guggenheim
Neutral
Mar 12, 25 Guggenheim
Neutral
Mar 10, 25 Guggenheim
Neutral
Mar 5, 25 B of A Securities
Neutral

Institutional Ownership

Similar stocks

UNH logo
UnitedHealth Group Incorporated (UNH)
ABBV logo
AbbVie (ABBV)
NVO logo
Novo Nordisk A/S (NVO)
ABT logo
Abbott Laboratories (ABT)
NVS logo
Novartis AG (NVS)
AZN logo
AstraZeneca (AZN)
MRK logo
Merck & Co (MRK)
ISRG logo
Intuitive Surgical (ISRG)
TMO logo
Thermo Fisher Scientific (TMO)
  • What is the ticker symbol for Johnson & Johnson?
  • Does Johnson & Johnson pay dividends?
  • What sector is Johnson & Johnson in?
  • What industry is Johnson & Johnson in?
  • What country is Johnson & Johnson based in?
  • When did Johnson & Johnson go public?
  • Is Johnson & Johnson in the S&P 500?
  • Is Johnson & Johnson in the NASDAQ 100?
  • Is Johnson & Johnson in the Dow Jones?
  • When was Johnson & Johnson's last earnings report?
  • When does Johnson & Johnson report earnings?
  • Should I buy Johnson & Johnson stock now?

What is the ticker symbol for Johnson & Johnson?

The ticker symbol for Johnson & Johnson is NYSE:JNJ

Does Johnson & Johnson pay dividends?

Yes, Johnson & Johnson pays dividends. The last payment was $1.24, with an ex-dividend date on February 18, 2025

What sector is Johnson & Johnson in?

Johnson & Johnson is in the Healthcare sector

What industry is Johnson & Johnson in?

Johnson & Johnson is in the Drug Manufacturers - General industry

What country is Johnson & Johnson based in?

Johnson & Johnson is headquartered in United States

When did Johnson & Johnson go public?

Johnson & Johnson's initial public offering (IPO) was on January 2, 1943

Is Johnson & Johnson in the S&P 500?

Yes, Johnson & Johnson is included in the S&P 500 index

Is Johnson & Johnson in the NASDAQ 100?

No, Johnson & Johnson is not included in the NASDAQ 100 index

Is Johnson & Johnson in the Dow Jones?

Yes, Johnson & Johnson is included in the Dow Jones index

When was Johnson & Johnson's last earnings report?

Johnson & Johnson's most recent earnings report was on Apr 15, 2025

When does Johnson & Johnson report earnings?

The next expected earnings date for Johnson & Johnson is Jul 16, 2025

Should I buy Johnson & Johnson stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page